Tamara R. Todorović

ORCID: 0000-0002-7740-3639
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Metal complexes synthesis and properties
  • Synthesis and biological activity
  • Synthesis and Characterization of Heterocyclic Compounds
  • Crystal structures of chemical compounds
  • Prostate Cancer Treatment and Research
  • Radiomics and Machine Learning in Medical Imaging
  • Computational Drug Discovery Methods
  • Organometallic Compounds Synthesis and Characterization
  • Prostate Cancer Diagnosis and Treatment
  • Magnetism in coordination complexes
  • Free Radicals and Antioxidants
  • HIV, Drug Use, Sexual Risk
  • HIV/AIDS Research and Interventions
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis C virus research
  • Organoselenium and organotellurium chemistry
  • vaccines and immunoinformatics approaches
  • Synthesis and Biological Evaluation
  • Crystallography and molecular interactions
  • Lanthanide and Transition Metal Complexes
  • Synthesis of Tetrazole Derivatives
  • Metal-Organic Frameworks: Synthesis and Applications
  • Protein Interaction Studies and Fluorescence Analysis

Artistic Realization Technologies
2023-2025

University of Belgrade
2015-2024

University of Belgrade – Faculty of Chemistry
2015-2023

Coherus BioSciences (United States)
2020-2021

Highland Hospital
2016-2021

Alameda Health System
2016-2018

Faculty (United Kingdom)
2017

Decipher (Decipher Biosciences Inc) is a genomic classifier (GC) developed to estimate the risk of distant metastasis (DM) after radical prostatectomy (RP) in patients with prostate cancer.To validate GC context randomized phase 3 trial.This ancillary study used RP specimens from placebo-controlled NRG/RTOG 9601 clinical trial conducted March 1998 2003. The were centrally reviewed, and RNA was extracted highest-grade tumor available 2019 median follow-up 13 years. Clinical-grade whole...

10.1001/jamaoncol.2020.7671 article EN JAMA Oncology 2021-02-12

PURPOSE The SPARTAN trial demonstrated that the addition of apalutamide to androgen deprivation therapy improves outcomes among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC). We applied a previously reported digital histopathology–based multimodal artificial intelligence (MMAI) algorithm estimate clinical in SPARTAN. METHODS Patients available hematoxylin and eosin-stained slides from primary tumor were included. Histopathology digitized. MMAI scores ranging 0 1...

10.1200/po-24-00653 article EN JCO Precision Oncology 2025-01-01

Abstract Purpose Oligometastatic castration-sensitive prostate cancer (omCSPC) is a clinically and biologically heterogeneous disease. A multimodal artificial intelligence (MMAI) algorithm (ArteraAI Prostate Test), which incorporates digital histopathology clinical information, prognostic for outcomes in localized cancer. We hypothesized MMAI algorithms are also omCSPC correlate with tumor biology. Thus, we aimed to evaluate the association between score vector features (VF) genomics of...

10.1158/1557-3265.targetedtherap-p007 article EN Clinical Cancer Research 2025-01-26

364 Background: Over the past decade, multiple biomarkers have been developed and validated to improve precision of prostate cancer prognosis estimation. However, these require access archival tissue central laboratory processing for RNA extraction, as a result are labor-intensive expensive. Deep learning models based on image analysis standard clinical pathology slides may offer similar accuracy with much improved lower cost. Multimodal artificial intelligence (MMAI) (Artera, Los Altos, CA)...

10.1200/jco.2025.43.5_suppl.364 article EN Journal of Clinical Oncology 2025-02-10

Background.Urban emergency departments (EDs) seem to be able detect new hepatitis C virus (HCV) infections at a high rate, but it is unknown the extent which individuals screened in ED can progress treatment and cure. We evaluate HCV Continuum of Care for patients identified with 2 urban EDs, consider results context outcomes from ambulatory screening venues where 2%–10% chronically infected are treated.

10.1093/cid/cix163 article EN Clinical Infectious Diseases 2017-02-15

The novel approach in the treatment of complex multifactorial diseases, such as neurodegenerative disorders and cancer, requires a development efficient multi-targeting oriented drugs. Since oxidative stress significantly contributes to pathogenesis cancer disorders, potential drug candidates should possess good antioxidant properties. Due promising biological activities shown for structurally related (1,3-thiazol-2-yl)hydrazones, focused library 12 benzylidene-based...

10.3389/fchem.2018.00247 article EN cc-by Frontiers in Chemistry 2018-07-03

Pseudomonas aeruginosa is one of the most dreaded human pathogens, because its intrinsic resistance to a number commonly used antibiotics and ability form sessile communities (biofilms). Innovative treatment strategies are required that can rely on attenuation pathogenicity virulence traits. The interruption mechanisms intercellular communication in bacteria (quorum sensing) such promising strategies. A cobalt coordination compound (Co(HL)₂) synthesized from...

10.3390/molecules23061385 article EN cc-by Molecules 2018-06-08
Jason S. Haukoos Michael S. Lyons Richard E. Rothman Douglas A.E. White Emily Hopkins and 95 more Meggan M. Bucossi Andrew H. Ruffner Rachel M. Ancona Yu‐Hsiang Hsieh Stephen Peterson Danielle Signer Matthew Toerper Mustapha Saheed Sarah K. Pfeil Tamara R. Todorović Alia Al‐Tayyib Lucy Bradley‐Springer Jonathan D. Campbell Edward M. Gardner Sarah E. Rowan Allison L. Sabel Mark Thrun B.P. Austin Jacob Cohen J. E. Easley Somiya Haider Peter Hill M. Bradford Henley Gabor D. Kelen Maggie Leathers Barbara Maliszewski Paula M. Neira Scott Newton Lucas Spaeth Tina Tolson Valentina G. Viertel Maddie Whalen Lindsay Bohanske Catherine Cronin Frank Fernandez Carl J. Fichtenbaum Cortney Gaffney Cathy Hamilton Kim Hart Dave Hoskins Sharon Kohrs Christopher J. Lindsell C. J. Miller Brittany E. Punches Geri Rowan Kim Vance Teresa A. Williams Steve Cantrill Angelica Chavez Ann Comeau Tracy Daugherty Alex J. Delgado Pamela Doyle Roberto Esquivel Maren Fassino Kelly Finnegan Greg Fliney Theresa Freudig Michael Fuhriman Mary Gillman Stacy Kahl-Geiger Korina Keating Jason Koerner Karen Laber Meghan Lang Carolynn Lyle Kim Makela Mary Maltby David Medina Tanya Nielsen Alice Ortiz A. Paolucci Don Pate Michael Pippins Steven Roy John Searcey Jerry Solot Kelly Stermer Brian Stuart Melissa Swanson Lauren Timkovich Zenia Toure Lisa Vogel Sommer Walker Diane Weed Julia Weise Kerri Wenke Courtney Wham Michael L. Wilson Jarrod Wright Melody Zwakenberg Harrison Alter Erik S. Anderson Brendan T. Campbell Grace Chang

<h3>Importance</h3> The National HIV Strategic Plan for the US recommends screening in emergency departments (EDs). most effective approach to ED-based remains unknown. <h3>Objective</h3> To compare strategies when integrated into usual ED practice. <h3>Design, Setting, and Participants</h3> This randomized clinical trial included patients visiting EDs at 4 urban hospitals between April 2014 January 2016. Patients were ages 16 years or older, not critically ill mentally altered, known have...

10.1001/jamanetworkopen.2021.17763 article EN cc-by-nc-nd JAMA Network Open 2021-07-26

Abstract In the current pandemic, finding an effective drug to prevent or treat infection is highest priority. A rapid and safe approach counteract COVID‐19 in silico repurposing. The SARS‐CoV‐2 PLpro promotes viral replication modulates host immune system, resulting inhibition of antiviral innate response, therefore attractive target. this study, we used a combined virtual screening for candidates protease inhibitors. We Informational spectrum method applied Small Molecules searching...

10.1002/open.202100248 article EN cc-by-nc-nd ChemistryOpen 2022-02-01

The synthesis and chemical characterization of the novel 2,6-diacetylpyridine-bis(selenosemicarbazone) metal complexes Zn(II), Cd(II) Ni(II) were published previously. Here we report first evidence on anti-proliferative activity molecular patterns that underlie it. corresponding ligand are shown to be cytotoxic panel nine, malignant non-malignant cell lines, with exception complex did not achieve IC50 value any lines tested. Further experiments selected including A 549, MRC-5, EA.hy 926...

10.2174/1573406410666140327122009 article EN Medicinal Chemistry 2014-10-23

Our previous studies showed that zinc (II), cadmium (II) and nickel complexes with 2-formylpyridine selenosemicarbazone induce apoptosis in cancer cells via activation of mitochondrial pathway. Herein, we reported their antimetastatic properties. Nickel exhibited the strongest inhibitory potential towards MMP-2/9, while all investigated compounds significantly decreased proteolytic activity MMP-2/9 human breast MDA-MB-361 cells. As shown by vitro transmembrane assays, complex was most...

10.2174/187152012803529682 article EN Anti-Cancer Agents in Medicinal Chemistry 2012-10-01

Study of antitumor activity mono- and bis-quinoline based (thio)carbohydrazones on THP-1 AsPC-1 cancer stem cells, revealed that thiocarbohydrazones had superior pro-apoptotic than carbohydrazones with multi-target profile activities.

10.1039/c6ra23940d article EN cc-by RSC Advances 2016-01-01
Coming Soon ...